Scientists find new mechanism by which cell signaling pathway contributes to rheumatoid arthritis development
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence ...
Immunology
May 20, 2012 |
5 / 5 (3) |
0
|
Master switch discovery could provide road map for treatment of arthritis and other inflammatory diseases
(Medical Xpress)—Scientists trying to create drugs to treat chronic inflammation in diseases like arthritis now have a new culprit known MMP2. New University of British Columbia research shows that this enzyme works as ...
Inflammatory disorders
Jan 23, 2013 |
not rated yet |
0
|
Gout study offers genetic insight into 'disease of kings'
Scientists have shed light on why some people are more susceptible to gout than others. A study has identified 18 new genetic variations that increase levels of uric acid in the blood, which is the main cause of the disease. ...
Genetics
Dec 23, 2012 |
4 / 5 (4) |
0
|
Scientists step up hunt for bacterial genes tied to Lyme disease
Investigators at The University of Texas Health Science Center at Houston (UTHealth) have accelerated the search for the bacterial genes that make the Lyme disease bacterium so invasive and persistent. The discovery could ...
Diseases, Conditions, Syndromes
Oct 26, 2012 |
not rated yet |
0
|
'Humanized' mice advance study of rheumatoid arthritis
Researchers at Northwestern University Feinberg School of Medicine have developed the first animal model that duplicates the human response in rheumatoid arthritis (RA), an important step that may enable scientists to discover ...
Arthritis & Rheumatism
Oct 04, 2012 |
not rated yet |
0
|
Even after Lyme disease is gone, its remains may perpetuate inflammation
(Medical Xpress) -- Non-infectious proteins of the species of bacteria that causes Lyme disease can remain in the body for a long time after antibiotic therapy, and are capable of causing an inflammatory immune ...
Inflammatory disorders
Jun 26, 2012 |
5 / 5 (1) |
0
|
For puzzling childhood immune disorder, gene research opens door to first diagnostic test
A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, ...
Genetics
May 11, 2011 |
3.3 / 5 (3) |
0
|
Foul-smelling gas shows health benefits in reducing joint swelling
A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis.
Arthritis & Rheumatism
Apr 29, 2013 |
not rated yet |
0
Can stem cells help those with arthritis?
Stems cells taken from just a few grams of body fat are a promising weapon against the crippling effects of osteoarthritis.
Arthritis & Rheumatism
Apr 28, 2013 |
not rated yet |
0
Ultrasound model IDs residual joint inflammation in RA
(HealthDay)—A model including ultrasound (US) assessment of the wrist, metacarpophalangeal (MCP), ankle, and metatarsophalangeal (MTP) joints is highly sensitive for detecting B-mode and Doppler joint inflammation ...
Arthritis & Rheumatism
Apr 18, 2013 |
not rated yet |
0
Scientists improve arthritis treatments: Rheumatism patients can hope for a new therapy
Together with colleagues from the international rheumatic diseases research community, scientists of the Charité – Universitätsmedizin Berlin have presented a new therapy approach for the treatment of rheumatoid arthritis ...
Arthritis & Rheumatism
Feb 14, 2013 |
5 / 5 (1) |
0
Research finds new therapy options for children with severe juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (SJIA) has long been considered a therapeutic orphan. Until now, the principal effective treatment has been high-dose steroids (prednisone) which are accompanied by several serious side ...
Arthritis & Rheumatism
Dec 21, 2012 |
not rated yet |
0
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism
Nov 07, 2012 |
not rated yet |
0
Studies explore racial disparities in IBD symptoms and therapy
Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
not rated yet |
0
New animal model for rheumatoid arthritis
Researchers at Northwestern University Feinberg School of Medicine have created the first animal model that spontaneously develops rheumatoid arthritis (RA) and is predisposed towards atherosclerosis, or hardening of the ...
Arthritis & Rheumatism
Jun 28, 2012 |
not rated yet |
0
